Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants. | MicrobiomeTrials
Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants.
CompletedPHASE1INTERVENTIONAL
Trial Details
Start: 2025-07-23Est. Completion: 2026-03-23
Enrollment target: 120 participants
Locations
Nucleus Network, Brisbane, Queensland, Australia
Nucleus Network, Melbourne, Victoria, Australia
Other microbiome trials you might be interested in